在自发高血压大鼠中,运动诱导的心脏线粒体重组和增强
Joshua Godoy Coto1, Erica V Pereyra1, Fiorella A Cavalli1
1Centro de Investigaciones Cardiovasculares "Dr. Horacio E. Cingolani", Facultad de Ciencias Médicas, Universidad Nacional de La Plata (UNLP) - CONICET, La Plata, Argentina.
Pflugers Archiv : European journal of physiology
|April 16, 2024
概括
像游泳一样,有氧运动训练改善了高血压大鼠的心脏功能和线粒体健康. 这种方法增强了心脏生物能量,并减少了病理性缩,为管理心脏病提供了潜在的策略.
科学领域:
- 心血管生理学心血管生理学
- 线粒体生物学 线粒体生物学
- 运动科学 运动科学
背景情况:
- 心肌主要依赖线粒体的能量生产来维持心脏功能.
- 病理性心脏缩会增加能量需求,可能压倒 mitochondrial 容量.
- 高血压引起的心脏缩对心脏健康和功能构成重大风险.
研究的目的:
- 研究慢性游泳训练对自发高血压大鼠心脏线粒体网络的影响.
- 评估运动对心脏功能的影响,缩标志物,氧化应激和线粒体生物能学在SHR.
- 探索运动诱导的心脏适应所涉及的潜在信号通路.
主要方法:
- 成年男性SHR接受了为期8周的游泳方案或保持久坐.
- 评估心脏功能使用心声回声和测量血压.
- 在心脏组织上进行了分子,成像和分离线粒体研究.
主要成果:
- 游泳训练改善了心脏缩短和降低了心房 natriuretic 水平,表明病理性缩减少.
- 在训练过的老鼠中,观察到线粒体空间分布,动力学,功能和ATP生产的显著改善.
- 运动增加了AKT和糖原合成酶激酶-3β的酸化,这是线粒体生物发生和完整性的关键调节者.
结论:
- 慢性有氧运动训练是改善高血压病理性心脏缩的有效策略.
- 游泳运动通过改善线粒体功能和完整性来增强心脏生物能量.
- 运动诱导的心脏健康的改善部分由胰岛素样生长因子1信号通路介导.
更多相关视频
相关概念视频
Exercise and Cardiac Output
1.0K
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
1.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422


